Literature DB >> 11869407

Use of hypoallergenic formula in the prevention of atopic disease among Asian children.

Y H Chan1, L P C Shek, M Aw, S H Quak, B W Lee.   

Abstract

OBJECTIVE: To determine the effect of a partially hydrolysed formula on genetically predisposed children, with respect to the development of atopic clinical manifestations and in vitro testing of serum IgE levels (total and milk-specific).
METHODS: One hundred and ten infants were randomly assigned to receive either partially hydrolysed formula or standard infant formula, and were prospectively monitored from birth for clinical atopic symptoms and serum IgE levels.
RESULTS: Eczema occurred less frequently in infants receiving partially hydrolysed formula. This was significant (P < 0.05) at 3, 6, 9, 12, 18 and 24 months. However, the significance decreased with time, although it almost reached statistical significance at 30 months by the Kaplan-Meier survival function (log-rank statistic, 3.46; P = 0.063). Although wheezing occurred less frequently in infants receiving partially hydrolysed formula, compared to those receiving standard infant formula, the difference did not reach statistical significance (P > 0.05).
CONCLUSIONS: Exclusive feeding of hypoallergenic milk formula in the first 4 months of life has a protective effect in terms of the development of atopic dermatitis in the first 2 years of life, compared to feeding with cow's milk formula.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11869407     DOI: 10.1046/j.1440-1754.2002.00725.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  12 in total

Review 1.  Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy.

Authors:  David A Osborn; John Kh Sinn; Lisa J Jones
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

2.  Economic value of using partially hydrolysed infant formula for risk reduction of atopic dermatitis in high-risk, not exclusively breastfed infants in Singapore.

Authors:  Marc F Botteman; Abhijeet J Bhanegaonkar; Erica G Horodniceanu; Xiang Ji; Bee Wah Lee; Lynette P Shek; Hugo Ps Van Bever; Patrick Detzel
Journal:  Singapore Med J       Date:  2017-12-07       Impact factor: 1.858

Review 3.  How should an incident case of atopic dermatitis be defined? A systematic review of primary prevention studies.

Authors:  Eric L Simpson; Laura E Keck; Joanne R Chalmers; Hywel C Williams
Journal:  J Allergy Clin Immunol       Date:  2012-03-15       Impact factor: 10.793

4.  Milk processing as a tool to reduce cow's milk allergenicity: a mini-review.

Authors:  Guanhao Bu; Yongkang Luo; Fusheng Chen; Kunlun Liu; Tingwei Zhu
Journal:  Dairy Sci Technol       Date:  2013-03-13

5.  Safety of a new extensively hydrolysed formula in children with cow's milk protein allergy: a double blind crossover study.

Authors:  Suzanne W J Terheggen-Lagro; Ilse M S L Khouw; Anne Schaafsma; Erik A K Wauters
Journal:  BMC Pediatr       Date:  2002-10-14       Impact factor: 2.125

6.  Economic value of atopic dermatitis prevention via infant formula use in high-risk Malaysian infants.

Authors:  Abhijeet J Bhanegaonkar; Erica G Horodniceanu; Amir Hamzah Abdul Latiff; Sanjay Woodhull; Phaik Choo Khoo; Patrick Detzel; Xiang Ji; Marc F Botteman
Journal:  Asia Pac Allergy       Date:  2015-04-29

7.  Development of β-lactoglobulin-specific chimeric human IgEκ monoclonal antibodies for in vitro safety assessment of whey hydrolysates.

Authors:  Karen Knipping; Peter J Simons; Laura S Buelens-Sleumer; Linda Cox; Marcel den Hartog; Niels de Jong; Reiko Teshima; Johan Garssen; Louis Boon; Léon M J Knippels
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

Review 8.  A partially hydrolyzed 100% whey formula and the risk of eczema and any allergy: an updated meta-analysis.

Authors:  Hania Szajewska; Andrea Horvath
Journal:  World Allergy Organ J       Date:  2017-07-26       Impact factor: 4.084

9.  Infant formulas containing hydrolysed protein for prevention of allergic disease.

Authors:  David A Osborn; John Kh Sinn; Lisa J Jones
Journal:  Cochrane Database Syst Rev       Date:  2018-10-19

Review 10.  Hydrolysed formula and risk of allergic or autoimmune disease: systematic review and meta-analysis.

Authors:  Robert J Boyle; Despo Ierodiakonou; Tasnia Khan; Jennifer Chivinge; Zoe Robinson; Natalie Geoghegan; Katharine Jarrold; Thalia Afxentiou; Tim Reeves; Sergio Cunha; Marialena Trivella; Vanessa Garcia-Larsen; Jo Leonardi-Bee
Journal:  BMJ       Date:  2016-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.